This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Hyperglucagonaemia
Information about Hyperglucagonaemia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Hyperglucagonaemia
Most recent studies have shown that Hyperglucagonaemia shares some biological mechanisms with diabetes-mellitus, diabetes-mellitus-experimental, diabetes-mellitus-insulin-dependent, diabetes-mellitus-non-insulin-dependent, erythema, glucagonoma, hyperglycemia, hyperinsulinism, hypoglycemia, hypoinsulinaemia, impaired-glucose-tolerance, insulin-resistance, insulin-sensitivity, islet-cell-adenoma, liver-cirrhosis, neoplasm-metastasis, neoplasms, obesity, pancreatic-neoplasm.
Among the many pathways, these few ones have gauged particular interests from scientists studying Hyperglucagonaemia, and have been seen in publications frequently: Acid Secretion, Amino Acid Transport, Cell Proliferation, Excretion, Gastric Acid Secretion, Gastric Emptying, Glomerular Filtration, Glucagon Secretion, Gluconeogenesis, Glucose Homeostasis, Glycolysis, Hormone Secretion, Insulin Secretion, Pathogenesis, Phagocytosis, Proteolysis, Regeneration, Regulation Of Glucagon Secretion, Secretion, Transport
Quite a number of genes have been found to play important roles in Hyperglucagonaemia, such as C1QTNF1, ERMAP, G6PC, GCG, GCGR, GGH, GH1, GIP, GNAI2, GNL3, IAPP, INS, KRAS, PPY, SLC25A5, SST. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.